Teratogenico - contraceção necessária durante e após 3 meses (homens) ou 1 ciclo ovulatório (mulheres)
Antídoto: Leucovorina
Interactions:
TMP-SMX: Cotrimoxazole rarely increases myelosuppression in patients receiving methotrexate, probably by additive antifolate effect
Sulfonamides (eg. dapsone, TMP-SMX): Sulfonamides can displace methotrexate from plasma protein-binding sites resulting in increased free methotrexate concentrations.
Tetracyclines: Possible increased methotrexate toxicity because of displacement from protein binding sites. Possible decreased intestinal absorption of methotrexate or interference with enterohepatic circulation.